(PharmaNewsWire.Com, May 23, 2017 ) According to the report Global Cancer Biomarkers Market, published by Market Data Forecast, the global market is projected to reach USD 17.2 billion by 2021, at a CAGR of 11.45% from 2016 to 2021.
Biomarkers are chemical, physical or biological parameters which can be used to specify disease states. Oncology biomarkers offers high speed, non-invasive cancer diagnosis and deem to improve cancer detection and screening. The global cancer biomarkers market is consolidated in nature at the top. In order to sustain their market shares, top players are constantly focusing on new product developments and improving their existing products to augment their product portfolios. Omics technologies segment is further sub segmented into Genomics, Proteomics, Metabolomics, Transcriptomics and Pharmacogenomics.
The factors impacting the Global Market for Cancer Biomarkers Market, either positively or negatively are presented in the DROC analysis. Some of the things discussed in the section are rationalized drug delivery procedure, non-invasive technology, augmented rates of survival. Boost in government and private funding for oncology also fuels the market growth. Market is constrained by high cost of diagnosis, issues associated to reimbursement and some of the regulatory policies which hamper the market growth.
For granular level understanding the Cancer Biomarkers Market is segmented based on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for each sub-segment. By Disease: Prostate Cancer Breast Cancer Lung Cancer Colorectal Cancer Cervical Cancer Other Cancers By Services: Sample Preparation Assay Development Biomarkers validation & testing By Application: Risk Assessment Development of molecular diagnostics Disease diagnosis Drug discovery Development and drug formulation By Type: Protein Biomarkers Genetic Biomarkers Other Biomarkers By Profiling Technologies: Omics technologies Genomics Proteomics Metabolomics Transcriptomics Pharmacogenomics Imaging technologies Immunoassays Cytogenetics Bioinformatics IVD multivariate index assays
Based on geography, the market is analysed under various regions namely, North America, Latin America, Europe, Asia-Pacific and Middle-East & Africa. The Asia-Pacific market is poised to record the highest growth rate in the forecast period due to the supporting government funding for cancer biomarker research, increasing prevalence of cancer, rising demand for advanced healthcare facilities in developing economies such as India and China, growing number of clinical trials, and rising focus of international players in emerging markets. North America Cancer Biomarkers Market Europe Cancer Biomarkers Market Asia-Pacific Cancer Biomarkers Market Latin America Cancer Biomarkers Market Middle East and Africa Cancer Biomarkers Market
Some of the major players in this market are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A., Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Clarient Inc, Diadexus Inc, Ambrilia Biopharma, Affymetrix Inc and Aureon Laboratories Inc.
The Cancer Biomarkers Market study offers the following deliverables:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is blooming Segment-level analysis on basis of type, application, end-user along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that effect the global market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Cancer Biomarkers Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
